BPI Labs manufactures these compounds and distributes them through healthcare providers, telehealth companies, and pharmacy networks
adults are taking them for weight loss in 2026, up from 3% in 2024
Patients with leaky gut, IBD, autoimmune diseases, and MCAS may benefit from combining these peptides with: Dietary protocols , such as gluten-free, anti-inflammatory, or autoimmune paleo diets
427 Many fusiform peptides of viral and non-viral origin, such as the INF7 family, 428 L17E family, 429 GALA/KALA family, 430,431,432 and HA family, 433 can disrupt endosomal membranes and increase cytoplasmic delivery
The reason for this gap: if a patient adds two new compounds on day one and gets nauseous, headachy, or unusually fatigued, we have no way to know which one is responsible
The answer is almost always: manageable, if you take sensible steps and ask for help when something feels wrong